Navigation Links
New AIDS vaccine may be in the offing

An article published in an online issue of Nature Medicine by researchers in Rene Descartes University has reported a stunning discovery of a bold new type of vaccine which may one day let people quit their AIDS drugs. The study which was carried// out on monkeys showed promising results, and if confirmed and adapted in humans may signal a major new therapeutic approach to HIV.

The researchers reported that the new vaccine uses a type of cell, commonly found in the skin, called dendritic cells or DCs. The main job of DCs is to grab foreign substances and turn them in to the immune system, which triggers a chain reaction that starts a powerful immune attack on similar substances. In the study, the researchers injected these cells (i.e. DCs) that were loaded with a killed AIDS virus into monkeys, infected with the same virus. The monkeys which would quickly die in normal conditions, were alive and did not get sick - at least for the 34-week study period, when they were given the vaccine treatment.

Most vaccines make the immune system do one of two things: make antibodies or make germ-killing cells while the DC vaccine elicited both kinds of immune responses. Researchers claim that these therapeutic approaches which used inactivated-virus-loaded DC vaccines to generate strong HIV-specific cellular and antibody immunities may result in long-term immunological control of chronic HIV disease. However, a major question which needs to be resolved is that of how long the vaccine-stimulated immune responses will keep the AIDS virus under control.


'"/>




Page: 1

Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. New vaccine helps allergy and asthma patients
5. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
6. HIV did not arise from polio vaccine
7. Double impact vaccine
8. High Demand for a child vaccine
9. A new vaccine for leukemia
10. Shortage of MMR vaccine
11. Anthrax vaccine produced
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... ... much more than energy – it also has mental and physical benefits. According to the ... which can increase the risk of having a car accident. , This week is ... help you sleep better and feel better:, , Turn off all ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back Surgery and ... revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, with ... revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional back ...
(Date:4/28/2017)... , ... April 28, 2017 , ... People are starting ... people. “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore ... Associates of Greater Boston, in a NALA North American Speaker Series (NASS) ...
(Date:4/28/2017)... ... 28, 2017 , ... Intellitec Solutions announced the publication of ... Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software package. With ... care, Brooke Grove now has the capability to achieve its goal for a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Christie Medical Holdings, Inc. , with its ... B. Braun Medical Inc. , a leader in infusion therapy and pain management. ... as 90 percent of hospital patients receiving a peripheral IV catheter as part of ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, Inc. ... on providing the Urology, Uro/Gyn and Gynecology markets ... Ash Keswani has joined the Company as Senior ... newly created position, Mr. Keswani will report directly ... "Our organization is delighted that Ash ...
(Date:4/20/2017)... MARLBOROUGH, Mass. , April 20, 2017 /PRNewswire/ ... company developing innovative therapeutics that address significant unmet ... new data from the Company,s consumer product development ... technology, at the Society for Investigative Dermatology (SID) ... is to advance and promote the sciences relevant ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: